PHENOXYBENZAMINE HYDROCHLORIDE
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- PHENOXYBENZAMINE HYDROCHLORIDE
- Generic name
- PHENOXYBENZAMINE HYDROCHLORIDE
- Manufacturer
- NorthStar Rx LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 48a047c0-f409-420b-990a-2cab953a96cd
- SPL ID
- fdce371e-19a7-43df-8c4f-6cb9ebb723cb
- Version
- 3
- Effective date
- 2026-07-09
- Source export date
- 2026-09-28
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:55:49
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 215600 | derived:openfda.application_number |
| application number | ANDA215600 | openfda.application_number | |
| brand name | PHENOXYBENZAMINE HYDROCHLORIDE | openfda.brand_name | |
| generic name | PHENOXYBENZAMINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | NorthStar Rx LLC | openfda.manufacturer_name | |
| ndc | package | 72603-229-01 | openfda.package_ndc |
| ndc | product | 72603-229 | openfda.product_ndc |
| ndc11 | package | 72603022901 | derived:openfda.package_ndc |
| rxcui | 861402 | openfda.rxcui | |
| spl id | fdce371e-19a7-43df-8c4f-6cb9ebb723cb | id | |
| spl set id | 48a047c0-f409-420b-990a-2cab953a96cd | set_id | |
| unii | X1IEG24OHL | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNING Phenoxybenzamine hydrochloride-induced alpha -adrenergic blockade leaves beta -adrenergic receptors unopposed. Compounds that stimulate both types of receptors may, therefore, produce an exaggerated hypotensive response and tachycardia.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following adverse reactions have been observed, but there are insufficient data to support an estimate of their frequency. Autonomic Nervous System*: Postural hypotension, tachycardia, inhibition of ejaculation, nasal congestion, miosis. *These so-called “side effects” are actually evidence of adrenergic blockade and vary according to the degree of blockade. Miscellaneous: Gastrointestinal irritation, drowsiness, fatigue. To report SUSPECTED ADVERSE REACTIONS, contact Northstar Rx LLC at 1-800-206-7821 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.